Earnings Scheduled For February 27, 2025

Benzinga03:32 ET

Here's the Major Earnings Before the Open Tomorrow

Seeking Alpha18:00 ET

Altimmune Expands Board Amid Late-Stage Drug Development

TipRanksFeb 25 07:58 ET

Express News | Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

ReutersFeb 25 07:30 ET

Press Release: Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

Dow JonesFeb 25 07:30 ET

TD Cowen raised the Global sales forecast for weight loss drugs until 2030, stating that "Nautilus" will continue to dominate the market.

TD Cowen Inc expects that as Eli Lilly and Co and Novo-Nordisk A/S continue to dominate, GLP-1 weight-loss drug global sales will reach 139 billion dollars by 2030, an increase of over 38% from previous forecasts.

Zhitong FinanceFeb 23 21:43 ET